Letters to the Editor

BRAFV600E-positive cells as molecular markers of bone marrow disease in pediatric Langerhans cell histiocytosis

Department of Pediatrics, Hirosaki University Graduate School of Medicine, Hirosaki
Department of Pediatrics, Hirosaki University Graduate School of Medicine, Hirosaki
Department of Pediatrics, Hirosaki University Graduate School of Medicine, Hirosaki
Department of Pediatrics, Hirosaki University Graduate School of Medicine, Hirosaki
Department of Pediatrics, Hirosaki University Graduate School of Medicine, Hirosaki
Department of Pediatrics, Hirosaki University Graduate School of Medicine, Hirosaki
Department of Pediatrics, Hirosaki University Graduate School of Medicine, Hirosaki
Department of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences, Niigata
Department of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences, Niigata
Department of Hematology and Oncology, Chiba Children's Hospital, Chiba
Department of Hematology and Oncology, Chiba Children's Hospital, Chiba
Department of Pediatrics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima
Department of Pediatrics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima
Department of Pediatrics, Tohoku University Graduate School of Medicine, Sendai
Department of Pediatrics, Tohoku University Graduate School of Medicine, Sendai
Department of Hematology and Oncology, Children's Cancer Center, Hyogo Prefectural Kobe Children's Hospital, Kobe
Department of Hematology and Oncology, Children's Cancer Center, Hyogo Prefectural Kobe Children's Hospital, Kobe
Department of Hematology and Oncology, Shizuoka Children's Hospital, Shizuoka
Department of Hematology and Oncology, Shizuoka Children's Hospital, Shizuoka
Children’s Cancer Center, National Center for Child Health and Development, Tokyo
Children’s Cancer Center, National Center for Child Health and Development, Tokyo
Children’s Cancer Center, National Center for Child Health and Development, Tokyo, Japan; Department of Pediatrics, Graduate School of Medicine, The University of Tokyo, Tokyo
Department of Pediatrics, Fujita Health University School of Medicine, Aichi
Department of Pediatrics, Yamaguchi University Graduate School of Medicine, Yamaguchi
Department of Hematology and Oncology, Miyagi Children's Hospital, Sendai
Department of Pediatrics, Nihon University Graduate School of Medicine, Tokyo
Department of Child Health and Development, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo
Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto
Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto
Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto
Department of Diagnostic Pathology, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Department of Pathology, Iwate Medical University, Iwate
Department of Anatomic Pathology, Hirosaki University Graduate School of Medicine, Hirosaki
Department of Clinical Research, Saitama Children's Medical Center, Saitama
Department of Pediatrics, Hirosaki University Graduate School of Medicine, Hirosaki
Department of Pediatrics, Hirosaki University Graduate School of Medicine, Hirosaki, Japan; Department of Community Medicine, Hirosaki University Graduate School of Medicine, Hirosaki
Haematologica Early view Mar 17, 2022 https://doi.org/10.3324/haematol.2021.279857